A detailed history of Strs Ohio transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Strs Ohio holds 124,300 shares of PSTX stock, worth $1.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
124,300
Previous 124,300 -0.0%
Holding current value
$1.17 Million
Previous $362,000 1.93%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$2.0 - $3.46 $25,400 - $43,942
12,700 Added 11.38%
124,300 $362,000
Q1 2024

May 13, 2024

BUY
$2.76 - $4.13 $252,539 - $377,895
91,500 Added 455.22%
111,600 $356,000
Q3 2023

Oct 26, 2023

BUY
$1.62 - $2.79 $32,562 - $56,079
20,100 New
20,100 $47,000
Q2 2021

Jul 26, 2021

SELL
$7.96 - $10.07 $27,064 - $34,238
-3,400 Closed
0 $0
Q3 2020

Dec 14, 2020

BUY
$8.09 - $16.25 $27,506 - $55,250
3,400 New
3,400 $30,000

Others Institutions Holding PSTX

About Poseida Therapeutics, Inc.


  • Ticker PSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,775,600
  • Market Cap $810M
  • Description
  • Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...
More about PSTX
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.